AI in Regulatory Affairs Market Report 2026

The artificial intelligence (AI) in regulatory affairs market size has grown exponentially in recent years. It will grow from $1.71 billion in 2025 to $2.11 billion in 2026 at a compound annual growth rate (CAGR) of 23%. The growth in the historic period can be attributed to increasing regulatory complexity in life sciences, growing volumes of regulatory documentation, rising demand for faster approvals, expansion of global clinical trials, increasing digitization of regulatory processes.

The artificial intelligence (AI) in regulatory affairs market size is expected to see exponential growth in the next few years. It will grow to $4.78 billion in 2030 at a compound annual growth rate (CAGR) of 22.7%. The growth in the forecast period can be attributed to increasing adoption of end-to-end regulatory automation, rising investments in cloud-based compliance platforms, growing use of predictive analytics for regulatory strategy, expansion of ai-enabled pharmacovigilance, increasing demand for regulatory efficiency. Major trends in the forecast period include increasing adoption of AI-driven regulatory intelligence platforms, rising use of automated submission management tools, growing integration of natural language processing in compliance, expansion of cloud-based regulatory solutions, enhanced focus on real-time regulatory monitoring.

The increasing adoption of AI-enabled platforms is expected to drive the growth of the artificial intelligence (AI) in regulatory affairs market in the coming years. AI-enabled platforms are digital systems that leverage artificial intelligence technologies such as machine learning, natural language processing, and predictive analytics to automate tasks, improve decision-making, and boost operational efficiency. The integration of these platforms is accelerating due to the growing demand for automation and streamlined management of complex regulatory processes, enabling faster data processing and higher accuracy in decision-making. AI in regulatory affairs facilitates compliance management, accelerates regulatory approvals, and improves data reliability, helping organizations bring products to market more efficiently. For instance, in October 2024, the UK’s AI sector generated USD 16.32 billion (£14.2 billion) in revenue in 2023, marking a 34% year-on-year increase, while AI-related employment rose to around 64,500, according to the Department for Science, Innovation and Technology (DSIT), a UK government organization. Therefore, the rising integration of AI-enabled platforms is driving growth in the AI in regulatory affairs market.

Companies in the AI in regulatory affairs market are focusing on innovations such as Regulatory Information Management (RIM) systems to centralize regulatory data, automate submission workflows, ensure global compliance, and enhance visibility throughout a product’s lifecycle. Regulatory information management involves the systematic collection, organization, and management of regulatory data, documents, and submissions to meet global compliance requirements and streamline communication with health authorities. For instance, in July 2024, ArisGlobal LLC, a US-based software company, launched the latest version of its LifeSphere Regulatory Platform. This cloud-based system integrates next-generation GenAI and large-language-model (LLM) capabilities through its LifeSphere NavaX engine, enabling content ingestion, generation, and deeper insights while achieving over 50% efficiency gains by unifying data, content, and processes within a single ecosystem and ensuring interoperability with ArisGlobal’s safety and quality systems, positioning it as a transformative solution for life-sciences regulatory workflows.

In October 2025, Ernst & Young Global Limited, a UK-based professional services firm, acquired Aqurance A.E. for an undisclosed amount. This acquisition strengthens Ernst & Young’s regulatory affairs and life sciences consulting capabilities by integrating Aqurance A.E.’s expertise in AI-driven regulatory solutions. The partnership enhances EY’s ability to streamline compliance processes and support global pharmaceutical and biotechnology clients in navigating complex regulatory landscapes. Aqurance A.E. is a Greece-based technology company specializing in AI applications for regulatory affairs.

Major companies operating in the artificial intelligence (AI) in regulatory affairs market are Freyr Software Services Private Limited, Celegence LLC, Wipro Limited, Indegene Limited, Clarivate Plc, Zenovel Pharma Services LLP, RegDesk Inc, Compliance.ai Inc, IONI AI INC., Interfacing Technologies Corporation, OneTrust LLC, Xapien Ltd., SpringsApps Technologies Pvt Ltd., Fairnow Inc., Navitas Life Sciences Private Limited, S&P Global Inc., International Business Machines Corporation, ZS Associates International Inc., Vistaar Technologies Inc., Lexim AI Inc.

North America was the largest region in the artificial intelligence (AI) in regulatory affairs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in regulatory affairs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) in regulatory affairs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the ai in regulatory affairs market by increasing costs of imported servers, data infrastructure hardware, software licensing components, and specialized it services used in cloud and on-premises deployments. Life sciences companies in North America and Europe are most affected due to reliance on global technology supply chains, while asia-pacific faces higher costs for enterprise software deployment. These tariffs are raising implementation costs and delaying digital transformation projects. However, they are also encouraging regional software development, localized cloud infrastructure investments, and innovation in cost-efficient regulatory technology solutions.

The artificial intelligence (AI) in regulatory affairs market research report is one of a series of new reports that provides artificial intelligence (AI) in regulatory affairs market statistics, including artificial intelligence (AI) in regulatory affairs industry global market size, regional shares, competitors with a artificial intelligence (AI) in regulatory affairs market share, detailed artificial intelligence (AI) in regulatory affairs market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in regulatory affairs industry. This artificial intelligence (AI) in regulatory affairs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI) in regulatory affairs refers to the use of AI technologies - such as machine learning, natural language processing, and automation - to optimize and streamline regulatory processes in pharmaceuticals, biotechnology, and medical devices. It helps manage large volumes of regulatory data, accelerates document review, ensures compliance with evolving regulations, and enhances decision-making accuracy. By automating repetitive tasks and analyzing complex datasets, AI enables faster submissions, minimizes errors, and improves communication with regulatory authorities.

The main components of AI in regulatory affairs are software/platforms and services. AI regulatory affairs software includes tools that use artificial intelligence to automate, streamline, and improve compliance processes, such as document management, submission tracking, and data analysis, ensuring faster and more accurate regulatory decision-making. Deployment modes include cloud-based and on-premises solutions. Applications cover regulatory intelligence, data migration and integration, dossier management, product registration and approvals, pharmacovigilance and safety reporting, regulatory submissions and publishing, and others. Key end-users include pharmaceutical companies, biotechnology companies, and other regulatory stakeholders.

The artificial intelligence (AI) in regulatory affairs market consists of revenues earned by entities by providing services such as risk assessment services, change management services, audit support services, pharmacovigilance services, and regulatory submission automation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in regulatory affairs market also includes sales of regulatory tools, and assessment tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.